Omeprazole Inhibits Pancreatic Cancer Cell Invasion through a Nongenomic Aryl Hydrocarbon Receptor Pathway

Chemical Research in Toxicology

Volumn 28, Issue 5, 2015, Pages 907-918

  Jin, Un Ho ^a   Kim, Sang Bae ^b   Safe, Stephen ^a,c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CHEMOKINE RECEPTOR CXCR4; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; OMEPRAZOLE; TRANILAST; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER CELL LINE; CANCER CELL; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; GENE SILENCING; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; REAL TIME POLYMERASE CHAIN REACTION; DRUG EFFECTS; FEMALE; METABOLISM; PANCREAS; PANCREATIC NEOPLASMS; PATHOLOGY; PREVENTION AND CONTROL; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CYTOCHROME P-450 CYP1A1; FEMALE; HUMANS; NEOPLASM INVASIVENESS; OMEPRAZOLE; PANCREAS; PANCREATIC NEOPLASMS; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION;

EID: 84929413600     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx5005198     Document Type: Article

References (48)

1. Gu, Y. Z., Hogenesch, J. B., and Bradfield, C. A. (2000) The PAS superfamily: sensors of environmental and developmental signals Annu. Rev. Pharmacol. Toxicol. 40, 519-561
2. Denison, M. S., Soshilov, A. A., He, G., DeGroot, D. E., and Zhao, B. (2011) Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor Toxicol. Sci. 124, 1-22
3. Poland, A., Glover, E., and Kende, A. S. (1976) Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo- p -dioxin by hepatic cytosol: evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase J. Biol. Chem. 251, 4936-4946
4. Stevens, E. A., Mezrich, J. D., and Bradfield, C. A. (2009) The aryl hydrocarbon receptor: a perspective on potential roles in the immune system Immunology 127, 299-311
5. Kerkvliet, N. I. (2009) AHR-mediated immunomodulation: the role of altered gene transcription Biochem. Pharmacol. 77, 746-760
6. Busbee, P. B., Rouse, M., Nagarkatti, M., and Nagarkatti, P. S. (2013) Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders Nutr. Rev. 71, 353-369
7. Safe, S., Lee, S. O., and Jin, U. H. (2013) Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target Toxicol. Sci. 135, 1-16
8. Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J. C., and Stockinger, B. (2008) The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins Nature 453, 106-109
9. Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., and Weiner, H. L. (2008) Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor Nature 453, 65-71
10. Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., Jugold, M., Guillemin, G. J., Miller, C. L., Lutz, C., Radlwimmer, B., Lehmann, I., von Deimling, A., Wick, W., and Platten, M. (2011) An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor Nature 478, 197-203
11. Min/+ mice with natural ligands Proc. Natl. Acad. Sci. U.S.A. 106, 13481-13486
12. Lee, J. S., Cella, M., McDonald, K. G., Garlanda, C., Kennedy, G. D., Nukaya, M., Mantovani, A., Kopan, R., Bradfield, C. A., Newberry, R. D., and Colonna, M. (2012) AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch Nat. Immunol. 13, 144-151
13. Li, Y., Innocentin, S., Withers, D. R., Roberts, N. A., Gallagher, A. R., Grigorieva, E. F., Wilhelm, C., and Veldhoen, M. (2011) Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation Cell 147, 629-640
14. Kiss, E. A., Vonarbourg, C., Kopfmann, S., Hobeika, E., Finke, D., Esser, C., and Diefenbach, A. (2011) Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles Science 334, 1561-1565
15. Arsenescu, R., Arsenescu, V., Zhong, J., Nasser, M., Melinte, R., Dingle, R. W., Swanson, H., and de Villiers, W. J. (2011) Role of the xenobiotic receptor in inflammatory bowel disease Inflammatory Bowel Dis. 17, 1149-1162
16. Singh, N. P., Singh, U. P., Singh, B., Price, R. L., Nagarkatti, M., and Nagarkatti, P. S. (2011) Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis PLoS One 6, e23522
17. Monteleone, I., Rizzo, A., Sarra, M., Sica, G., Sileri, P., Biancone, L., MacDonald, T. T., Pallone, F., and Monteleone, G. (2011) Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract Gastroenterology 141, 237-248
18. Furumatsu, K., Nishiumi, S., Kawano, Y., Ooi, M., Yoshie, T., Shiomi, Y., Kutsumi, H., Ashida, H., Fujii-Kuriyama, Y., Azuma, T., and Yoshida, M. (2011) A role of the aryl hydrocarbon receptor in attenuation of colitis Dig. Dis. Sci. 56, 2532-2544
19. Benson, J. M. and Shepherd, D. M. (2011) Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease Toxicol. Sci. 120, 68-78
20. Hu, W., Sorrentino, C., Denison, M. S., Kolaja, K., and Fielden, M. R. (2007) Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro Mol. Pharmacol. 71, 1475-1486
21. Denison, M. S., Seidel, S. D., Rogers, W. J., Ziccardi, M. H., Winter, G. M., and Heath-Pagliuso, S. (1998) Natural and synthetic ligands for the Ah receptor, in Molecular Bioloy Approaches to Toxicology (Puga, A. and Kendall, K. B., Eds.) pp 3-33, Taylor and Francis, London.
22. Jeuken, A., Keser, B. J., Khan, E., Brouwer, A., Koeman, J., and Denison, M. S. (2003) Activation of the Ah receptor by extracts of dietary herbal supplements, vegetables, and fruits J. Agric. Food Chem. 51, 5478-5487
23. Safe, S., Chadalapaka, G., and Jutooru, I. (2012) AHR-reactive compounds in the human diet, in The Ah Receptor in Biology and Toxicology (Pohjanvirta, R., Ed.) pp 331-342, John Wiley & Sons, Hoboken, NJ.
24. DiNatale, B. C., Murray, I. A., Schroeder, J. C., Flaveny, C. A., Lahoti, T. S., Laurenzana, E. M., Omiecinski, C. J., and Perdew, G. H. (2010) Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling Toxicol. Sci. 115, 89-97
25. Oberg, M., Bergander, L., Hakansson, H., Rannug, U., and Rannug, A. (2005) Identification of the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole, in cell culture medium, as a factor that controls the background aryl hydrocarbon receptor activity Toxicol. Sci. 85, 935-943
26. Wincent, E., Amini, N., Luecke, S., Glatt, H., Bergman, J., Crescenzi, C., Rannug, A., and Rannug, U. (2009) The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6-formylindolo[3,2- b ]carbazole is present in humans J. Biol. Chem. 284, 2690-2696
27. Lu, Y. F., Santostefano, M., Cunningham, B. D., Threadgill, M. D., and Safe, S. (1996) Substituted flavones as aryl hydrocarbon (Ah) receptor agonists and antagonists Biochem. Pharmacol. 51, 1077-1087
28. Kim, S. H., Henry, E. C., Kim, D. K., Kim, Y. H., Shin, K. J., Han, M. S., Lee, T. G., Kang, J. K., Gasiewicz, T. A., Ryu, S. H., and Suh, P. G. (2006) Novel compound 2-methyl-2 H -pyrazole-3-carboxylic acid (2-methyl-4- o -tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor Mol. Pharmacol. 69, 1871-1878
29. Smith, K. J., Murray, I. A., Tanos, R., Tellew, J., Boitano, A. E., Bisson, W. H., Kolluri, S. K., Cooke, M. P., and Perdew, G. H. (2011) Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism J. Pharmacol. Exp. Ther. 338, 318-327
30. Murray, I. A., Flaveny, C. A., Chiaro, C. R., Sharma, A. K., Tanos, R. S., Schroeder, J. C., Amin, S. G., Bisson, W. H., Kolluri, S. K., and Perdew, G. H. (2011) Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3′,4′-dimethoxy-alpha-naphthoflavone Mol. Pharmacol. 79, 508-519
31. Li, W. and Matsumura, F. (2008) Significance of the nongenomic, inflammatory pathway in mediating the toxic action of TCDD to induce rapid and long-term cellular responses in 3T3-L1 adipocytes Biochemistry 47, 13997-14008
32. Huang, G. and Elferink, C. J. (2012) A novel nonconsensus xenobiotic response element capable of mediating aryl hydrocarbon receptor-dependent gene expression Mol. Pharmacol. 81, 338-347
33. Jackson, D. P., Li, H., Mitchell, K. A., Joshi, A. D., and Elferink, C. J. (2014) Ah receptor-mediated suppression of liver regeneration through NC-XRE-driven p21Cip1 expression Mol. Pharmacol. 85, 533-541
34. Jin, U. H., Lee, S. O., and Safe, S. (2012) Aryl hydrocarbon receptor (AHR)-active pharmaceuticals are selective AHR modulators in MDA-MB-468 and BT474 breast cancer cells J. Pharmacol. Exp. Ther. 343, 333-341
35. Jin, U. H., Lee, S. O., Pfent, C., and Safe, S. (2014) The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis BMC Cancer 14, 498
36. McGuire, J., Okamoto, K., Whitelaw, M. L., Tanaka, H., and Poellinger, L. (2001) Definition of a dioxin receptor mutant that is a constitutive activator of transcription: delineation of overlapping repression and ligand binding functions within the PAS domain J. Biol. Chem. 276, 41841-41849
37. Boitano, A. E., Wang, J., Romeo, R., Bouchez, L. C., Parker, A. E., Sutton, S. E., Walker, J. R., Flaveny, C. A., Perdew, G. H., Denison, M. S., Schultz, P. G., and Cooke, M. P. (2010) Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells Science 329, 1345-1348
38. Collisson, E. A., Sadanandam, A., Olson, P., Gibb, W. J., Truitt, M., Gu, S., Cooc, J., Weinkle, J., Kim, G. E., Jakkula, L., Feiler, H. S., Ko, A. H., Olshen, A. B., Danenberg, K. L., Tempero, M. A., Spellman, P. T., Hanahan, D., and Gray, J. W. (2011) Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy Nat. Med. 17, 500-503
39. Labruzzo, P., Yu, X. F., and Dufresne, M. J. (1989) Induction of aryl hydrocarbon hydroxylase and demonstration of a specific nuclear receptor for 2,3,7,8-tetrachlorodibenzo- p -dioxin in two human hepatoma cell lines Biochem. Pharmacol. 38, 2339-2348
40. Stejskalova, L., Vecerova, L., Perez, L. M., Vrzal, R., Dvorak, Z., Nachtigal, P., and Pavek, P. (2011) Aryl hydrocarbon receptor and aryl hydrocarbon nuclear translocator expression in human and rat placentas and transcription activity in human trophoblast cultures Toxicol. Sci. 123, 26-36
41. Koliopanus, A., Kleeff, J., Xiao, Y., Safe, S., Zimmerman, A., Buchler, M. W., and Friess, H. (2002) Increased aryl hydrocarbon receptor expression offers a potential therapeutic target in pancreatic cancer Oncogene 21, 6059-6070
42. Zhang, S., Rowlands, C., and Safe, S. (2008) Ligand-dependent interactions of the Ah receptor with coactivators in a mammalian two-hybrid assay Toxicol. Appl. Pharmacol. 227, 196-206
43. Src Environ. Toxicol. Pharmacol. 3, 211-220
44. Dong, B. and Matsumura, F. (2009) The conversion of rapid TCCD nongenomic signals to persistent inflammatory effects via select protein kinases in MCF10A cells Mol. Endocrinol. 23, 549-558
45. Andersson, P., McGuire, J., Rubio, C., Gradin, K., Whitelaw, M. L., Pettersson, S., Hanberg, A., and Poellinger, L. (2002) A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors Proc. Natl. Acad. Sci. U.S.A. 99, 9990-9995
46. DiNatale, B. C., Smith, K., John, K., Krishnegowda, G., Amin, S. G., and Perdew, G. H. (2012) Ah receptor antagonism represses head and neck tumor cell aggressive phenotype Mol. Cancer Res. 10, 1369-1379
47. Li, W., Vogel, C. F., Wu, D., and Matsumura, F. (2010) Non-genomic action of TCDD to induce inflammatory responses in HepG2 human hepatoma cells and in liver of C57BL/6J mice Biol. Chem. 391, 1205-1219
48. Tomkiewicz, C., Herry, L., Bui, L. C., Metayer, C., Bourdeloux, M., Barouki, R., and Coumoul, X. (2013) The aryl hydrocarbon receptor regulates focal adhesion sites through a non-genomic FAK/Src pathway Oncogene 32, 1811-1820